Why is Neuland Laboratories Ltd ?
- PBT LESS OI(Q) At Rs 46.43 cr has Fallen at -21.7% (vs previous 4Q average)
- ROCE(HY) Lowest at 14.48%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.80 times
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.35%, its profits have fallen by -25.4%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.06% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to Neuland Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuland Labs. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 953.98 cr has Grown at 34.58%
Higher at Rs 137.42 cr
At Rs 46.43 cr has Fallen at -21.7% (vs previous 4Q average
Lowest at 14.48%
Lowest at 2.80 times
At Rs 40.57 cr has Fallen at -17.1% (vs previous 4Q average
Lowest at Rs 56.56 cr
Highest at 0.16 times
Lowest at 3.48 times
Highest at Rs 6.79 cr
Here's what is working for Neuland Labs.
Net Sales (Rs Cr)
Here's what is not working for Neuland Labs.
PBT less Other Income (Rs Cr)
Interest Paid (Rs cr)
PAT (Rs Cr)
Inventory Turnover Ratio
Interest Paid (Rs cr)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
Non Operating Income






